CAS: 2113650-04-5
BMS-1001 hydrochloride
CAS:2113650-04-5
BMS-1001 hydrochloride is an orally active inhibitor of human PD-1/PD-L1 immune checkpoint with low-toxicity in …
Fórmula:
C35H35ClN2O7
Pureza:
97.36%
Forma y color:
Solid
Peso molecular:
631.11
Ref: TM-T10565
1mg | 56,00 € | ||
5mg | 125,00 € | ||
10mg | 194,00 € | ||
25mg | 394,00 € | ||
50mg | 632,00 € | ||
100mg | 1.003,00 € | ||
200mg | 1.359,00 € | ||
1mL*10mM (DMSO) | 172,00 € |
Entrega estimada en Estados Unidos, el Miércoles 4 de Diciembre de 2024
N-[[2-[(3-Cyanophenyl)methoxy]-4-[[3-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-methylphenyl]methoxy]-5-methylphenyl]methyl]-D-serine hydrochloride
CAS:2113650-04-5
Fórmula:
C35H35ClN2O7
Pureza:
98%
Forma y color:
Solid
Peso molecular:
631.1146
Ref: IN-DA01LITV
1mg | 114,00 € | ||
5mg | 243,00 € | ||
10mg | 532,00 € | ||
25mg | A consultar |
Entrega estimada en Estados Unidos, el Miércoles 4 de Diciembre de 2024
BMS-1001 hydrochloride
CAS:2113650-04-5
BMS-1001 hydrochloride is a peptide that is an activator of ion channels. It has been …
Fórmula:
C35H35ClN2O7
Pureza:
Min. 95%
Peso molecular:
631.1 g/mol
Ref: 3D-NJD65004
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar |
Entrega estimada en Estados Unidos, el Miércoles 15 de Enero de 2025